AISSAOUI, Hamed,BOSS, Christoph,BOUIS, Patrick,HAZEMANN, Julien,SIEGRIST, Romain,VON RAUMER, Markus
申请号：
EP16769914
公开号：
EP3350179A1
申请日:
2016.09.14
申请国别(地区):
EP
年份:
2018
代理人:
摘要：
The invention relates to a crystalline form of (S)-2-(8-((5-chloropyrimidin-2-yl)(methyl)amino)- 2-fluoro-6,7,8,9-tetrahydro-5H-pyrido[3,2-b]indol-5-yl)acetic acid, processes for the preparation thereof, pharmaceutical compositions comprising said crystalline forms, pharmaceutical compositions prepared from such crystalline forms, and their use as a medicament, especially as CRTH2 receptor modulators.
